Efficacy and safety of tyrosine kinase inhibitor combined with venetoclax based regimen in pediatric patients with chronic myeloid leukemia in the blast phase: A single-centre retrospective study
Zheng F et al. Pediatr Blood Cancer, September 2026
Link to full abstract